Nanolive has released it’s next generation immunotherapy solution: the LIVE T Cell Assay. This real-time digital assay combines label-free live cell imaging and AI-powered analysis to deliver continuous, multiparametric data – ranging from T cell activation to target cell interactions and killing.
Watch the product release, where we showcase the versatility of the LIVE T Cell Assay through case studies featuring CAR-T and bispecific antibody screening, highlighting the assay’s ability to characterize immunotherapeutic specificity, robustness, and efficacy, as well as its value across different stages of preclinical research and development.
Read our latest news
Online demo: Rethink high content screening workflows for smarter decisions
Get a look into Nanolive’s workflow in this on-demand Online Demo, as our Field Application Specialist, Matthias Schade, guides us through the insights gained from a high content phenotypic screen.
Unlocking mitochondrial stress as a drug discovery readout
Mitochondrial stress can act as an early warning biomarker for drug candidate toxicity and can appear hours before conventional cell viability results. Discover case study data demonstrating how mitochondrial stress can be used as an early warning biomarker for cytotoxicity prediction.
Trends in AI analysis for live cell imaging
We review recent peer-reviewed studies that relied on noninvasive live-cell imaging to study immuno-oncology, cellular metabolism and disease progression in 2025, and share how advances in image analysis are supporting consistent interpretation of complex live-cell data in preclinical research.